French Glendon E. III's Form 4 filing
Pulmonx Corp (LUNG) · filed Sep 3, 2026
- Accession no.
- 0001805624-26-000004
- Filed
- Sep 3, 2026, 6:23 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $94.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| French Glendon E. IIICIK 0001805624 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | SSaleDisposed | −4,098 | $2.26 | −$9,261.48 | 1,175,720 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −37,784 | $2.26 | −$85,391.84 | 1,137,936 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.